Colorectal cancer (CRC) is a severe risk to public health, and there is growing evidence that alternative splicing (AS) plays a crucial role in cancer. However, the AS biomarkers in CRC are seldom reported. In this study, we perform transcriptome analysis of colorectal samples for cancer-specific AS and transcriptomic alterations. We identify 1577 splice events in 885 genes, enriched in CRC-associated pathways and functions. In parallel, we find 10 splicing factors (SFs) with transcriptome variation or significant differential expression. Based on co-expression and binding motif, we construct an SF-AS regulatory network, revealing the association between cancer-specific AS and aberrant SF. Integrating The Cancer Genome Atlas and published sources, we observed that some recurrent AS is an indicator of poor prognosis. Through further experimental verification, we found that the AS of six genes showed significant differences between the tumor sample and the normal sample, and AS of TCF7, COL12A1, GK, and UBA1 can be used as new potential biomarkers in CRC. Our study provides an important analysis of CRC-associated AS, which could act as a starting point for future functional explorations, the development of biomarkers and AS-based target therapy.
Get full access to this article
View all access options for this article.
References
1.
AmelioI., CutruzzoláF., AntonovA., AgostiniM., and MelinoG. (2014). Serine and glycine metabolism in cancer. Trends Biochem Sci, 39, 191–198.
2.
AndersS., ReyesA., and HuberW. (2012). Detecting differential usage of exons from RNA-seq data. Genome Res, 22, 2008–2017.
3.
BalinskaK., WilkD., FilipekB., MikM., ZelgaP., SkubelP., et al. (2019). Association of XRCC6 C1310G and LIG4 T9I polymorphisms of NHEJ DNA repair pathway with risk of colorectal cancer in the Polish population. Pol Przegl Chir, 91, 15–20.
4.
BergK.C., EideP.W., EilertsenI.A., JohannessenB., BruunJ., DanielsenS.A., et al. (2017). Multi-omics of 34 colorectal cancer cell lines-a resource for biomedical studies. Mol Cancer 16,116.
5.
BisogninA., PizziniS., PerilliL., EspositoG., MocellinS., NittiD., et al. (2014). An integrative framework identifies alternative splicing events in colorectal cancer development. Mol Oncol, 8, 129–141.
Cancer Genome Atlas Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature 487,330.
8.
CeramiE., GaoJ., DogrusozU., GrossB.E., SumerS.O., AksoyB.A., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov, 2, 401–404.
9.
ChenJ., and WeissW. (2015). Alternative splicing in cancer: implications for biology and therapy. Oncogene 34,1.
10.
CiprianoR., MiskimenK.L., BrysonB.L., FoyC.R., BartelC.A., and JacksonM.W. (2014). Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res, 12, 1156–1165.
11.
Climente-GonzálezH., Porta-PardoE., GodzikA., and EyrasE. (2017). The functional impact of alternative splicing in cancer. Cell Rep, 20, 2215–2226.
12.
CookA.D., SingleR., and McCahillL.E. (2005). Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol, 12, 637–645.
DuanS., GongB., WangP., HuangH., LuoL., and LiuF. (2018). Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG. Mol Med Rep, 18, 3727–3736.
15.
GaoM., ZhongA., PatelN., AlurC., and VyasD. (2017). High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases. World J Gastroenterol 23,2819.
16.
GonçalvesV., and JordanP. (2015). Posttranscriptional regulation of splicing factor SRSF1 and its role in cancer cell biology. Biomed Res Int 2015,287048.
17.
JinQ., PanL., LiuT., and HuF. (2015). RNA-seq based on transcriptome reveals differ genetic expressing in Chlamys farreri exposed to carcinogen PAHs. Environ Toxicol Pharmacol, 39, 313–320.
18.
JungH., LeeD., LeeJ., ParkD., KimY.J., ParkW.-Y., et al. (2015). Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat Genet 47,1242.
19.
KimD., LangmeadB., and SalzbergS.L. (2015). HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12,357.
20.
KimS.-K., KimS.-Y., KimJ.-H., RohS.A., ChoD.-H., KimY.S., et al. (2014). A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients. Mol Oncol, 8, 1653–1666.
21.
LeK.-Q., PrabhakarB.S., HongW.-J., and LiL.-C. (2015). Alternative splicing as a biomarker and potential target for drug discovery. Acta Pharmacol Sin 36,1212.
22.
LeeT.V., DingT., ChenZ., RajendranV., ScherrH., LackeyM., et al. (2008). The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously. Development, 135, 43–52.
23.
LiT., ZhuJ., WangX., ChenG., SunL., ZuoS., et al. (2017). Long non-coding RNA lncTCF7 activates the Wnt/β-catenin pathway to promote metastasis and invasion in colorectal cancer. Oncol Lett, 14, 7384–7390.
24.
LiuM., TangQ., QiuM., LangN., LiM., ZhengY., et al. (2011). miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett, 585, 2998–3005.
25.
McKennaA., HannaM., BanksE., SivachenkoA., CibulskisK., KernytskyA., et al. (2010). The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res, 20, 1297–1303.
26.
MrowickiJ., Przybylowska-SygutK., DzikiL., SygutA., ChojnackiJ., DzikiA., et al. (2014). The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population. Mol Biol Rep 41,4639.
27.
Muñoz, Ú., PucheJ.E., HannivoortR., LangU.E., Cohen-NaftalyM., and FriedmanS.L. (2012). Hepatocyte growth factor enhances alternative splicing of the Krüppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Mol Cancer Res, 10, 1216–1227.
28.
NagaokaK., FujiiK., ZhangH., UsudaK., WatanabeG., IvshinaM., et al. (2016). CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene 35,2893.
29.
OlteanS., and BatesD. (2014). Hallmarks of alternative splicing in cancer. Oncogene 33,5311.
30.
PazI., KostiI., AresM.Jr., ClineM., and Mandel-GutfreundY. (2014). RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res, 42, W361–W367.
31.
PerteaM., PerteaG.M., AntonescuC.M., ChangT.-C., MendellJ.T., and SalzbergS.L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33,290.
32.
PingY., DengY., WangL., ZhangH., ZhangY., XuC., et al. (2015). Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data. Nucleic Acids Res, 43, 1997–2007.
33.
PivaF., GiuliettiM., BuriniA.B., and PrincipatoG. (2012). SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat, 33, 81–85.
34.
QiaoJ., FangC.-Y., ChenS.-X., WangX.-Q., CuiS.-J., LiuX.-H., et al. (2015). Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Oncotarget 6,29929.
35.
RyanM., WongW.C., BrownR., AkbaniR., SuX., BroomB., et al. (2015). TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res, 44, D1018–D1022.
36.
SiegelR., DesantisC., and JemalA. (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin, 64, 104–117.
37.
SkrdlantL., StarkJ.M., and LinR.-J. (2016). Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C. BMC Mol Biol 17,18.
38.
SteinU., and SchlagP.M. (2007). Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res, 176, 61–80.
39.
SunR., GaoC.-L., LiD.-H., LiB.-J., and DingY.-H. (2017). Expression status of PIWIL1 as a prognostic marker of colorectal cancer. Dis Markers 2017,1204937.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
